Your Global Leader in Stem Cell Market Research
Because cord blood present within a newborn’s umbilical is rich with stem cells, it can be collected and stored for future medical use.
November 9, 2022, ELK CITY, Idaho — Therapeutic Solutions International (TSOI) announced the launching of a spin-off company, Breathe Biologics, Inc., to commercialize technologies in the area of COPD. [Read more…]
Fight the signs of premature aging with these stem cell skin care beauty products. A lot of companies claim to incorporate the benefits of plant and human stem cells, as well as components secreted by them, into the best stem cell beauty products on the market.
Below, we present what appears (based on company claims) to be ten of the best products available today. [Read more…]
The global cord blood industry experienced strong growth from the early 1990’s through the late 2000’s, during which time more than 450 cord blood banking companies emerged worldwide. Approximately half of those companies owned their own labs, while the others were marketing entities or sub-contractors of storage space.
Starting about ten years ago, the market suddenly changed course. It entered a period of aggressive consolidation, cutting the global number of cord blood banks by approximately half.
Over the past decade, the cord blood industry has witnessed substantial consolidation, particularly within the United States, Europe, Asia, and Latin America. [Read more…]
Looking to make a decision about U.S. cord blood banks? The sortable list below includes all Public, Private, and Hybrid Cord Blood Banks in the United States.
For those analyzing cord blood market dynamics, Cord Blood Registry (CBR) is the largest U.S. cord blood bank with over 925,000 cord blood and tissue units in storage. The next two largest cord blood banks within the U.S. are Viacord and Cryo-Cell.
In aggregate, there are a large number of public and private banks of varying sizes, as shown in the table below.
Over the past 30 years, cord blood and cord tissue have gained popularity and commercial traction due to the valuable stem cells they contain. According to ClinicalTrials.gov, there are over 1,360 clinical trials evaluating the use of cord blood and tissue-derived cells. These studies typically leverage unmanipulated whole cord blood (total nucleated cells/TNC), mononuclear cells (MNC), or cord blood-derived mesenchymal stem cells (MSCs). [Read more…]
